The Community Guide

- gsearch

Search Results

Narrow Results:

2020 2
2015 1

HPV-IMPACT Working Group 2

Journal Article 3

1 - 3 of 3 Results

Refine Results

Refine Results:

Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18

CITE Title : Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18 Personal Author(s) : Johnson Jones, Michelle L.;Gargano, Julia Warner;Powell, Melissa;Park, Ina U.;Niccolai, Linda M.;Bennett, Nancy M.;Griffin, Marie R.;Querec, Troy;Unger, Elizabeth R.;Markowitz, Lauri E.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : 4 02 2020;4-02-; Source : Am J Epidemiol. 189(4):265-276 URL : https://stacks.cdc.gov/view/cdc/115080 Johnson Jones, Michelle L. et al. (2020). Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18. 189(4). Johnson Jones, Michelle L. et al. "Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18" 189, no. 4 (2020) Johnson Jones, Michelle L. et al. "Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18" vol. 189, no. 4, 2020 Export RIS Citation Information.

:

Johnson Jones, Michelle L. ;

Gargano, Julia Warner

4 02 2020 | Am J Epidemiol. 189(4):265-276

:

Before 2016, human papillomavirus (HPV) vaccination was recommended on a 3-dose schedule. However, many vaccine-eligible US females received fewer tha...
Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆

CITE Title : Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆ Personal Author(s) : Hariri, Susan;Bennett, Nancy M.;Niccolai, Linda M.;Schafer, Sean;Park, Ina U.;Bloch, Karen C.;Unger, Elizabeth R.;Whitney, Erin;Julian, Pamela;Scahill, Mary W.;Abdullah, Nasreen;Levine, Diane;Johnson, Michelle L.;Steinau, Martin;Markowitz, Lauri E.; Published Date : February 11 2015 Source : Vaccine. 33(13):1608-1613 URL : https://stacks.cdc.gov/view/cdc/94604 Hariri, Susan et al. (2015). Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆. 33(13). Hariri, Susan et al. "Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆" 33, no. 13 (2015) Hariri, Susan et al. "Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆" vol. 33, no. 13, 2015 Export RIS Citation Information.

:

Hariri, Susan ;

Bennett, Nancy M.

February 11 2015 | Vaccine. 33(13):1608-1613

:

Background:Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but demonstrating impact on these lesions is impeded b...
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015

CITE Title : Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015 Personal Author(s) : Cleveland, Angela A.;Gargano, Julia W.;Park, Ina U.;Griffin, Marie R.;Niccolai, Linda M.;Powell, Melissa;Bennett, Nancy M.;Saadeh, Kayla;Pemmaraju, Manideepthi;Higgins, Kyle;Ehlers, Sara;Scahill, Mary;Jones, Michelle L. Johnson;Querec, Troy;Markowitz, Lauri E.;Unger, Elizabeth R.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : 2 01 2020;2-01-; Source : Int J Cancer. 146(3):810-818 URL : https://stacks.cdc.gov/view/cdc/117627 Cleveland, Angela A. et al. (2020). Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015. 146(3). Cleveland, Angela A. et al. "Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015" 146, no. 3 (2020) Cleveland, Angela A. et al. "Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015" vol. 146, no. 3, 2020 Export RIS Citation Information.

:

Cleveland, Angela A.

;

Gargano, Julia W.

2 01 2020 | Int J Cancer. 146(3):810-818

:

Primary prevention through the use of human papillomavirus (HPV) vaccination is expected to impact both cervical intraepithelial neoplasia (CIN) and a...